Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Genetic Expression Pattern of Gastric Carcinomas According to Cellular Mucin Phenotypes

´ëÇѺ´¸®ÇÐȸÁö 2007³â 41±Ç 5È£ p.307 ~ 315
ÀÌ¿ø¾Ö, À¯¿Ï½Ä, ¹èÇÑÀÍ, ¼­Àμö, Li Ying-Hua, ¾öÁöÇö,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ¿ø¾Ö ( Lee Won-Ae ) 
´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

À¯¿Ï½Ä ( Yu Wan-Sik ) 
°æºÏ´ëÇб³º´¿ø ¿Ü°ú
¹èÇÑÀÍ ( Bae Han-Ik ) 
°æºÏ´ëÇб³º´¿ø Çغκ´¸®°ú
¼­Àμö ( Suh In-Soo ) 
´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
 ( Li Ying-Hua ) 
´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¾öÁöÇö ( Eum Ji-Hyun ) 
´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Background : Gastric carcinomas (GCs) have recently been reclassified according to the mucin phenotypes. We aimed to characterize the relationship between the mucin phenotypes and the genetic alterations or the clinicopathologic parameters of GCs.

Methods : Immunohistochemistry was performed for MUC1, MUC5AC, MUC6, MUC2, CD10, p53, hMLH1, C-erbB2 and E-cadherin in 150 GCs. The mucin phenotypes of the GCs were classified as 4 phenotypes: gastric, intestinal, mixed and unclassified.

Results : MUC1, MUC5AC, MUC6, MUC2 and CD10 were expressed in 63.3%, 42.7%, 14.0%, 24.7% and 14.0% of the GCs, respectively. The mucin phenotypes of the GCs corresponded to the gastric type in 31.3%, the intestinal type in 20.0%, the mixed type in 15.3% and the unclassified type in 33.3%. The incidence of a p53 overexpression was higher in the gastric or mixed phenotype than in the intestinal or unclassified phenotype. MUC5AC expression, p53 overexpression and the gastric or mixed phenotype were associated with poor patient survival by multivariate analysis.

Conclusion : This study suggests the gastric or mixed mucin phenotype may more likely go through the p53 pathway in carcinogenesis and the mucin phenotype may be considered as a prognostic indicator.

Å°¿öµå

Stomach;Carcinoma;Mucins;TP53 protein;hMLH1 protein;ERBB2 protein;Ecadherin

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS